TCL Archive In Brief: NCI-Litton Negations On Frederick continue; Staffs Not Worried About Possible GAO Probe July 15, 1977
TCL Archive Progression-free survival as a primary endpoint for drug approval requires prospective planning, FDA’s Pazdur says. May 7, 2004
